Convergent Dental, Inc., developer of the industry-leading 9.3 µm CO2 all-tissue Solea® laser, is excited to announce a rapid relief treatment for the 90+ million adults who snore.
“We are thrilled to announce an all-new, easy to administer protocol for dentists who participate in, or are eager to enter, the growing field of dental sleep medicine,” said Michael Cataldo, Chief Executive Officer of Convergent Dental. “Solea Sleep will add even more value to customers who want to offer the latest and best treatments to their patients.”
A unique application of Solea’s advanced technology enables dentists to gently tighten tissue in the soft palate in a simple, 5-minute treatment, reducing vibrations that cause patients to snore and disrupt sleep. The product is currently in limited market release and will be available beginning in May of 2020.
"After 8 years of using an erbium laser to treat patients with airway issues,” said Anthony Bolamperti, DDS, of Omaha Laser Dentistry, “I consider Solea Sleep to be a quantum leap forward, allowing me to accomplish in a single 5-minute treatment what used to require three or four 30-minute treatments. My patients are experiencing immediate snoring relief and better quality of sleep for them and their partners.”
For more information about Solea, please visitconvergentdental.comor call 844.GOSOLEA.
